Literature DB >> 19623562

A predictive high-throughput scale-down model of monoclonal antibody production in CHO cells.

Rachel Legmann1, H Brett Schreyer, Rodney G Combs, Ellen L McCormick, A Peter Russo, Seth T Rodgers.   

Abstract

Multi-factorial experimentation is essential in understanding the link between mammalian cell culture conditions and the glycoprotein product of any biomanufacturing process. This understanding is increasingly demanded as bioprocess development is influenced by the Quality by Design paradigm. We have developed a system that allows hundreds of micro-bioreactors to be run in parallel under controlled conditions, enabling factorial experiments of much larger scope than is possible with traditional systems. A high-throughput analytics workflow was also developed using commercially available instruments to obtain product quality information for each cell culture condition. The micro-bioreactor system was tested by executing a factorial experiment varying four process parameters: pH, dissolved oxygen, feed supplement rate, and reduced glutathione level. A total of 180 micro-bioreactors were run for 2 weeks during this DOE experiment to assess this scaled down micro-bioreactor system as a high-throughput tool for process development. Online measurements of pH, dissolved oxygen, and optical density were complemented by offline measurements of glucose, viability, titer, and product quality. Model accuracy was assessed by regressing the micro-bioreactor results with those obtained in conventional 3 L bioreactors. Excellent agreement was observed between the micro-bioreactor and the bench-top bioreactor. The micro-bioreactor results were further analyzed to link parameter manipulations to process outcomes via leverage plots, and to examine the interactions between process parameters. The results show that feed supplement rate has a significant effect (P < 0.05) on all performance metrics with higher feed rates resulting in greater cell mass and product titer. Culture pH impacted terminal integrated viable cell concentration, titer and intact immunoglobulin G titer, with better results obtained at the lower pH set point. The results demonstrate that a micro-scale system can be an excellent model of larger scale systems, while providing data sets broader and deeper than are available by traditional methods. 2009 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19623562     DOI: 10.1002/bit.22474

Source DB:  PubMed          Journal:  Biotechnol Bioeng        ISSN: 0006-3592            Impact factor:   4.530


  8 in total

Review 1.  Cell culture processes for monoclonal antibody production.

Authors:  Feng Li; Natarajan Vijayasankaran; Amy Yijuan Shen; Robert Kiss; Ashraf Amanullah
Journal:  MAbs       Date:  2010-09-01       Impact factor: 5.857

2.  Digital Twins and Their Role in Model-Assisted Design of Experiments.

Authors:  Kim B Kuchemüller; Ralf Pörtner; Johannes Möller
Journal:  Adv Biochem Eng Biotechnol       Date:  2021       Impact factor: 2.635

3.  Novel Cell-Ess ® supplement used as a feed or as an initial boost to CHO serum free media results in a significant increase in protein yield and production.

Authors:  Adam Elhofy
Journal:  Comput Struct Biotechnol J       Date:  2016-08-03       Impact factor: 7.271

4.  Process development of human multipotent stromal cell microcarrier culture using an automated high-throughput microbioreactor.

Authors:  Qasim A Rafiq; Mariana P Hanga; Thomas R J Heathman; Karen Coopman; Alvin W Nienow; David J Williams; Christopher J Hewitt
Journal:  Biotechnol Bioeng       Date:  2017-07-27       Impact factor: 4.530

5.  Effects of diluents on cell culture viability measured by automated cell counter.

Authors:  Aaron Chen; Matthew Leith; Roger Tu; Gurpreet Tahim; Anish Sudra; Swapnil Bhargava
Journal:  PLoS One       Date:  2017-03-06       Impact factor: 3.240

6.  Use of High-Throughput Automated Microbioreactor System for Production of Model IgG1 in CHO Cells.

Authors:  Sai Rashmika Velugula-Yellela; Casey Kohnhorst; David N Powers; Nicholas Trunfio; Anneliese Faustino; Phillip Angart; Erica Berilla; Talia Faison; Cyrus Agarabi
Journal:  J Vis Exp       Date:  2018-09-28       Impact factor: 1.355

7.  Enhancing the functionality of a microscale bioreactor system as an industrial process development tool for mammalian perfusion culture.

Authors:  David J Sewell; Richard Turner; Ray Field; William Holmes; Rahul Pradhan; Christopher Spencer; Stephen G Oliver; Nigel Kh Slater; Duygu Dikicioglu
Journal:  Biotechnol Bioeng       Date:  2019-02-20       Impact factor: 4.530

Review 8.  The process defines the product: what really matters in biosimilar design and production?

Authors:  Arnold G Vulto; Orlando A Jaquez
Journal:  Rheumatology (Oxford)       Date:  2017-08-01       Impact factor: 7.580

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.